The term sleep disordered breathing encompasses a spectrum of abnormalities, including
snoring, obstructive sleep apnoea (OSA), central sleep apnoea (CSA), respiratory‐related …

Study Objectives: Modafinil is a wake-promoting agent shown to improve wakefulness in
patients with excessive sleepiness (hypersomnolence) associated with shift work sleep …

Smoking and OSA are widely prevalent and are associated with significant morbidity and
mortality. It has been hypothesized that each of these conditions adversely affects the other …

Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA)
allows for consolidation and determination of the key factors important for clinical …

Background: Modafinil is a novel wakepromoting agent that has US Food and Drug
Administration approval for narcolepsy and shift work sleep disorder and as adjunctive …

There is currently no pharmacotherapy for obstructive sleep apnoea (OSA) but there is no
principled a priori reason why there should not be one. This review identifies a rational …

Obstructive sleep apnoea (OSA) is a common disorder characterized by the repetitive
complete or partial collapse of the upper airway during sleep. It results in intermittent …

Obstructive sleep apnoea (OSA) is a major challenge for physicians and healthcare systems
throughout the world. The high prevalence and the impact on daily life of OSA oblige …

Obstructive sleep apnea (OSA) is a condition of repetitive upper airway collapse, which
occurs during sleep. Recent literature has emphasized the role of OSA in contributing to …

Study Objectives: The aim was to investigate how the severity of apneas, hypopneas, and
related desaturations is associated with obstructive sleep apnea (OSA)-related daytime …